Las Vegas, NV -- (SBWIRE) -- 10/23/2013 -- Beststocksondemand.com is a financial newsletter and blog focused on shedding light on under-discovered small cap companies. Our team of professionals from various backgrounds works diligently to bring our members the best penny stock picks, stock market commentary, and news on all types of OTCBB and Pink Sheet companies: Hickory Tech Corporation (NASDAQ:HTCO), DURECT Corporation (NASDAQ:DRRX), Odyssey Marine Exploration Inc (NASDAQ:OMEX), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)
Hickory Tech Corporation (NASDAQ:HTCO) gained volume of 102,579 shares and the average volume of the stock remained 21,298 shares. The 52 week range of the stock remained $8.91- $13.01 and the day range was $11.46 - $13.01.The stock opened the session at $11.52, and closed the session at $12.82. The stock showed a positive performance of 12.26% in previous trading session. HickoryTech Corporation (HickoryTech) is an integrated communications provider. HickoryTech has a five-state fiber network spanning more than 3,250 route miles with facilities-based operations across Minnesota and into Iowa, North Dakota, South Dakota and Wisconsin. Enventis Telecom, Inc. (Enventis) provides business Internet protocol (IP) voice, data and video solutions, Multi-Protocol Label Switching (MPLS) networking, data center and managed hosted services and communication systems. HickoryTech delivers broadband, Internet, digital television (TV), voice and data services to businesses and consumers in southern Minnesota and northwest Iowa.
For How Long HTCO will fight for Profitability? Read This Trend Analysis report
In previous session, DURECT Corporation (NASDAQ:DRRX) traded 5.29 million shares and the average volume of the stock remained 576,828 shares. The 52 week range of the stock remained $0.61 - $1.85. The stock was a bull and advanced 11.43 %, while its closing price stayed at $1.56. The market capitalization of the stock remained 159.16 million. The half-yearly trend of the stock remained positive 20 %. Durect Corporation is a specialty pharmaceutical company focused on the development of pharmaceutical products based on its drug delivery technology platforms. The Company’s product pipeline, as of December 31, 2012, consisted of eight investigational drug candidates in clinical development, with one program the subject of a New Drug Application (NDA) with the United States Food and Drug Administration (FDA), with one program in Phase III with an NDA in preparation, two programs in Phase II and three programs in Phase I.
For How Long DRRX Gloss will Attract Investors? Find out via this report
Odyssey Marine Exploration Inc (NASDAQ:OMEX) volume of the stock was 2.83 million shares in the most recent session and the average volume remained 820,178 shares. The stock boosted 11.41% and finished the prior session at the closing price of $2.93. Odyssey Marine Exploration, Inc. is engaged in archaeologically sensitive exploration and recovery of deep-ocean shipwrecks worldwide. The Company employs technology, including side-scan sonar, magnetometers, remotely operated vehicles (ROVs), and other advanced equipment that enables the Company to locate shipwrecks and natural resource sites at depths.
Will OMEX Continue To Move Higher? Find Out Here
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) traded with volume of 14.11million shares and the average volume of the stock remained 13.94 million shares. The stock grew 10.88% and finished the trading at $3.26. The market capitalization of the stock remained 603.45 million. The beta of the stock remained 1.17. ARIAD Pharmaceuticals, Inc. (ARIAD) is a global oncology company focused on the discovery, development and commercialization of medicines for the cancer patients. ARIAD’s first medicine, Iclusig, is approved in the United States for the treatment of adult patients with chronic, accelerated or blast phase chronic myeloid leukemia that is resistant or intolerant to prior tyrosine kinase inhibitor (TKI) therapy or Philadelphia chromosome-positive acute lymphoblastic leukemia that is resistant or intolerant to prior TKI therapy.
Why Should Investors Buy ARIA After The Recent Gain? Just Go Here and Find Out
About: Best Stock on Demand
Beststocksondemand.com is an exciting online financial terminal where stock reader, traders and investors as well as market analysts can come to discover new opportunities, ideas, situations and news. Beststocksondemand.com goal is finding the most Undervalued or should we say Value Stocks or the Next Emerging Growth Stock that might be unnoticed by Wall Street. Beststocksondemand.com is constantly searching for exceptional investment situations that can profit both investors and traders in order to grow their gains on a well balanced portfolio.
Beststocksondemand.com is also a well-respected marketing and research firm that mainly focuses on Best Stocks on Demand, Micro-Cap Stocks and Small Cap Stocks. Beststocksondemand.com uses its strategic corporate communication services to increase investor awareness of your company. We can support developing, emerging growth and deep-rooted companies in their marketing therefore creating a more dominant and operative investor alertness.
The assembled information disseminated by Beststocksondemand.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Beststocksondemand.com does expect that investors will buy and sell securities based on information assembled and presented in beststocksdaily.com. PLEASE always do your own due diligence, and consult your financial advisor.
Please read Our Full Disclaimer at: http://www.beststocksondemand.com/disclaimer.html
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)